BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27554492)

  • 1. Marked improvement in the success rate of medical management of early pregnancy failure following the implementation of a novel institutional protocol and treatment guidelines: a follow-up study.
    Colleselli V; Nell T; Bartosik T; Brunner C; Ciresa-Koenig A; Wildt L; Marth C; Seeber B
    Arch Gynecol Obstet; 2016 Nov; 294(6):1265-1272. PubMed ID: 27554492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of early pregnancy failure (EPF): a retrospective analysis of a combined protocol of mifepristone and misoprostol used in clinical practice.
    Colleselli V; Schreiber CA; D'Costa E; Mangesius S; Wildt L; Seeber BE
    Arch Gynecol Obstet; 2014 Jun; 289(6):1341-5. PubMed ID: 24305748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.
    van den Berg J; Hamel CC; Coppus SF; Snijders MP; Vandenbussche FP
    J Obstet Gynaecol; 2019 Oct; 39(7):1006-1011. PubMed ID: 31215270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of missed abortion: comparison of medical treatment with either mifepristone + misoprostol or misoprostol alone with surgical evacuation. A multi-center trial in Copenhagen county, Denmark.
    Grønlund A; Grønlund L; Clevin L; Andersen B; Palmgren N; Lidegaard Ø
    Acta Obstet Gynecol Scand; 2002 Nov; 81(11):1060-5. PubMed ID: 12421175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical methods for first trimester abortion.
    Kulier R; Gülmezoglu AM; Hofmeyr GJ; Cheng LN; Campana A
    Cochrane Database Syst Rev; 2004; (1):CD002855. PubMed ID: 14973995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-administration of vaginal misoprostol after mifepristone for termination of pregnancy: patient acceptability.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2006 Oct; 26(7):679-81. PubMed ID: 17071439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.
    van den Berg J; van den Bent JM; Snijders MP; de Heus R; Coppus SF; Vandenbussche FP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():16-9. PubMed ID: 25461345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation.
    Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ
    Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of mifepristone and misoprostol for the medical management of early pregnancy failure].
    Bouschbacher L; Maatouk A; Collin P; Welter E; Morel O; de Malartic CM
    Gynecol Obstet Fertil; 2014 Dec; 42(12):832-7. PubMed ID: 25458806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical management of early pregnancy failure: efficacy.
    Chen BA; Creinin MD
    Semin Reprod Med; 2008 Sep; 26(5):411-22. PubMed ID: 18825609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review.
    Raymond EG; Shannon C; Weaver MA; Winikoff B
    Contraception; 2013 Jan; 87(1):26-37. PubMed ID: 22898359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-administration of misoprostol for termination of pregnancy: safety and efficacy.
    Kiran U; Amin P; Penketh RJ
    J Obstet Gynaecol; 2004 Feb; 24(2):155-6. PubMed ID: 14766452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, Safety, and Acceptability of Low-Dose Mifepristone and Self-Administered Misoprostol for Ultra-Early Medical Abortion: A Randomized Controlled Trial.
    Li CL; Song LP; Tang SY; Zhou LJGY; He H; Mo XT; Liao YM
    Reprod Sci; 2017 May; 24(5):731-737. PubMed ID: 27678099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Misoprostol: off-label use in the first trimester of pregnancy (spontaneous abortion, and voluntary medical termination of pregnancy)].
    Beucher G; Dolley P; Carles G; Salaun F; Asselin I; Dreyfus M
    J Gynecol Obstet Biol Reprod (Paris); 2014 Feb; 43(2):123-45. PubMed ID: 24433988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone and misoprostol for early pregnancy failure: a cohort analysis.
    Kollitz KM; Meyn LA; Lohr PA; Creinin MD
    Am J Obstet Gynecol; 2011 May; 204(5):386.e1-6. PubMed ID: 21306697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial.
    Carbonell JL; Gallego FG; Llorente MP; Bermudez SB; Sala ES; González LV; Texido CS
    Contraception; 2007 Mar; 75(3):230-7. PubMed ID: 17303495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision.
    Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B
    Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.